Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 41,020 | 57,481 | 57,990 | 53,167 | 53,371 |
| Receivables | 25,768 | 23,690 | 22,187 | 23,955 | 21,987 |
| Inventories | 22,838 | 18,787 | 16,284 | 16,922 | 21,336 |
| TOTAL | $93,561 | $103,358 | $101,590 | $99,317 | $102,509 |
| Non-Current Assets | |||||
| PPE Net | 39,722 | 40,324 | 40,684 | 41,083 | 40,461 |
| Intangibles | 9,542 | 9,704 | 9,701 | 9,717 | 9,704 |
| Other Non-Current Assets | 36,562 | 36,884 | 37,462 | 37,565 | 37,931 |
| TOTAL | $85,826 | $86,912 | $87,847 | $88,365 | $88,096 |
| Total Assets | $179,387 | $190,270 | $189,437 | $187,682 | $190,605 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,339 | 6,041 | 4,732 | 4,771 | 5,277 |
| Accrued Expenses | 14,627 | 15,867 | 14,357 | 11,310 | 12,624 |
| TOTAL | $20,966 | $21,908 | $19,089 | $16,081 | $17,901 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 24,520 | 24,897 | 23,543 | 23,929 | 24,307 |
| TOTAL | $24,520 | $24,897 | $23,543 | $23,929 | $24,307 |
| Total Liabilities | $45,486 | $46,805 | $42,632 | $40,010 | $42,208 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13,306 | 13,401 | 14,421 | 14,418 | 14,341 |
| Common Shares | 133 | 139 | 144 | 144 | 143 |
| Retained earnings | 55,731 | 60,787 | 60,495 | 62,824 | 66,794 |
| Other shareholders' equity | -5,310 | -4,959 | -4,939 | -4,755 | -6,103 |
| TOTAL | $133,901 | $143,465 | $146,805 | $147,672 | $148,397 |
| Total Liabilities And Equity | $179,387 | $190,270 | $189,437 | $187,682 | $190,605 |